by admin | Sep 2, 2022 | news articles
By Vivienne Raper, PhD – Genengnews.com The future of cell therapies should be in off-the-shelf products using multiplex gene editing during the manufacturing process. That’s according to Rachel Haurwitz, PhD, CEO of Caribou Biosciences. Haurwitz, whose...
